AngioDynamics Action

AngioDynamics Endettement net

Endettement Net de AngioDynamics (ANGO) au 14 août 2026 est 37,16 M USD. L'année précédente, Endettement Net était -49,69 M USD — une variation de -174,78 % (plus élevé).

Endettement net

37,16 MUSD

YoY

-174,78%

Dernière mise à jour:

Endettement Net de AngioDynamics est 2026 37,16 M USD. Endettement Net de AngioDynamics était 2025 -49,69 M USD. Elle diminue ainsi de -174,78% plus élevé par rapport à l'année précédente.
Access this data via the Eulerpool API

AngioDynamics Analyse d'actions

Que fait AngioDynamics ? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics' focus is on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the field of Vascular Access Solutions, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary in the treatment of serious illnesses. These include port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment solutions, including ultrasound-guided radiofrequency ablation systems and fusion biopsy systems. Developing innovative diagnostic and treatment options is a key focus of AngioDynamics. A large portion of AngioDynamics' products are in the area of Peripheral Vascular Solutions. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases, such as varicosis or chronic venous insufficiency. This includes minimally invasive procedures such as laser and radiofrequency treatments. Due to its high-quality products, innovative technologies, and close collaboration with medical professionals, AngioDynamics has gained an excellent reputation in the medical industry. The company places great importance on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Throughout its years of existence, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action AngioDynamics

Endettement Net de AngioDynamics s'élève à 37,16 M USD en 2026.

Endettement Net de AngioDynamics a changé de -49,69 M USD à 37,16 M USD, ce qui représente une variation de -174,78 %. La valeur est plus élevé qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de AngioDynamics de Endettement Net depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

L'endettement net est la dette totale moins les espèces et équivalents de trésorerie. Il montre le fardeau réel de la dette après comptabilisation des ressources liquides disponibles.

USD de Endettement Net est un facteur clé pour les investisseurs. Les changements dans cette métrique peuvent signaler une amélioration ou une détérioration des fondamentaux, impactant directement le cours de l'action. Sur Eulerpool, vous pouvez suivre AngioDynamics de Endettement Net historiquement et en temps réel.

Access this data via the Eulerpool API

Bilan — AngioDynamics

Toutes les Métriques Clés — AngioDynamics

Croissance